Israeli Drug Could Eliminate 50% of Corona Deaths; Israel Sees ‘Light at End of Corona Tunnel
A drug called Aviptadil shows promise in defeating the syndrome that accounts for around half of all corona-related deaths.
United with Israel, April 1, 2020:
An Israeli company called Neurorx is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities.
On Sunday, the U.S. Food and Drug Administration gave approval to NeuroRx for phase two trials of Aviptadil.
While this is not a complete drug approval for Covid-19-related use of the drug, it does mean the treatment is one step closer to getting the greenlight for patient use.
Have a tip we should know? Your anonymity is NEVER compromised. Email firstname.lastname@example.org
The Truth Must be Told
Your contribution supports independent journalism
Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.
Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.
Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.
Please contribute here.
Make a monthly commitment to support The Geller Report – choose the option that suits you best.